Ashley Love Sumrall Announced as Candidate for ASCO Board of Directors

Ashley Love Sumrall Announced as Candidate for ASCO Board of Directors

Ashley Love Sumrall, MD, FACP, FASCO, a neuro-oncology specialist and academic leader at Atrium Health Levine Cancer Institute, has been announced as a candidate for the American Society of Clinical Oncology (ASCO) Board of Directors.

With a professional background spanning neuro-oncology, medical education, healthcare policy, and professional advocacy, Dr. Sumrall brings experience in both clinical oncology and organizational leadership.

Her previous service as Chair of ASCO’s Government Relations Committee and as a member of the Association for Clinical Oncology Board of Directors reflects her longstanding involvement in issues affecting oncology professionals, healthcare policy, and cancer care delivery.

At the Intersection of Neuro-Oncology and Academic Medicine

Dr. Sumrall currently serves as Clinical Associate Professor at Wake Forest University School of Medicine and as Associate Professor and Section Chief of Neuro-Oncology within the Atrium Health Department of Medicine.

Her academic and clinical appointments place her in a leadership position within a highly specialized field of cancer care.

Neuro-oncology addresses some of the most complex challenges in oncology, including the diagnosis and management of primary brain tumors and other cancers affecting the central nervous system.

The specialty requires close collaboration across medical oncology, radiation oncology, neurosurgery, neuroradiology, and other disciplines, making multidisciplinary coordination an essential part of patient management.

Through her clinical and academic responsibilities, Dr. Sumrall works within an area of medicine where advances in research, treatment, and supportive care remain particularly important.

Beyond Clinical Practice: A Voice in Oncology Policy

Dr. Sumrall’s professional contributions extend beyond academic medicine and clinical care.

She previously served as Chair of the ASCO Government Relations Committee, a position connected to the Society’s engagement with public policy and legislative issues affecting oncology.

The committee’s work addresses matters relevant to the oncology workforce, cancer care delivery, and the policy environment in which clinicians and patients navigate treatment.

Her leadership in this area reflects an understanding that advances in cancer treatment must be accompanied by policies that support access to appropriate care.

For oncologists, decisions made at the policy level can influence clinical practice, healthcare resources, and the ability of patients to receive recommended treatments.

Dr. Sumrall’s experience in government relations therefore represents an important dimension of her candidacy.

Leadership Within the Association for Clinical Oncology

In addition to her work with ASCO’s Government Relations Committee, Dr. Sumrall has served as a member of the Association for Clinical Oncology Board of Directors.

The Association for Clinical Oncology focuses on advocacy and policy matters affecting cancer care and the oncology profession.

Board service within the organization provides experience in professional governance and engagement with issues that extend beyond individual institutions.

Her participation in these activities has connected her clinical background with broader discussions about the conditions under which oncology care is delivered.

This combination of clinical expertise, academic responsibilities, and organizational experience is particularly relevant to leadership within a major professional oncology society.

Bringing Clinical Experience Into Oncology Leadership

Dr. Sumrall’s candidacy comes at a time when oncology organizations continue to address questions surrounding access to cancer care, the sustainability of clinical practice, and the translation of medical advances into routine treatment.

Her background offers perspectives from several areas of the profession: specialized cancer care, academic medicine, healthcare advocacy, and organizational governance.

As Section Chief of Neuro-Oncology, she holds a leadership role within a clinical specialty. Through her previous ASCO and Association for Clinical Oncology appointments, she has also participated in discussions affecting the broader oncology community.

These experiences provide a foundation for potential service on the ASCO Board of Directors.

The Next Chapter in ASCO Leadership

Dr. Ashley Love Sumrall’s candidacy represents another step in a career combining specialized oncology practice with professional service.

Her previous leadership roles in government relations and oncology advocacy, together with her academic and clinical appointments, have positioned her within both the medical and policy dimensions of cancer care.

If elected, she would bring this experience to the ASCO Board of Directors, contributing to the Society’s governance and its work on behalf of oncology professionals and the patients they serve.

As the election approaches, her candidacy highlights the importance of clinical expertise and policy engagement in shaping the future of oncology leadership.

Discover more articles like this on OncoDaily.

Vahe Grigoryan
Fact checked by Vahe Grigoryan MD, Editorial Director
Vahe Grigoryan
Medically reviewed by Vahe Grigoryan MD, Editorial Director